Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

TAG:

testing laboratory

Labs Should Prepare for Tighter CLIA Enforcement

CEO SUMMARY: Lab directors and pathologists should take notice of disturbing new developments in enforcement of CLIA regulations. During the past year, CMS officials have revoked the CLIA certification of several hospital laboratories for what are, essentially, inadvertent violations of p…

Read More



Lab/Path M&A Day Explores High Prices Paid to Lab Owners

IF YOU HAVEN’T NOTICED, there’s a gold rush in diagnostics! Prices paid for clinical laboratories, anatomic pathology group practices, and in vitro diagnostic (IVD) companies have soared recently. This is good news for pathologists and laboratory owners interested in putting their laboratory on …

Read More



Key Trends Drive Change for Clinical Laboratories

CEO SUMMARY: Technology plays an ever-growing role in reshaping the organization and operation of clinical laboratories. New technologies figure prominently in THE DARK REPORT’S 2007 list of key trends in the clinical laboratory industry. Technological advances in instr…

Read More



Increased Competition For Hospital Lab Referrals

CEO SUMMARY: It’s a buyer’s market for hospital send-out testing because the supply of such tests exceeds demand. To fill excess capacity in their labs, some reference/esoteric lab companies are willing to offer rock-bottom prices to new clients. This situation is also motivating nati…

Read More



April 10, 2006 “Intelligence: Late Breaking Lab News”

Another private lab company appears to have sold for a strong price. On March 21, 2006, American Capital Strategies Ltd. of Bethesda, Maryland, announced that it had invested $79.5 million in Redwood Toxicology Laboratory Inc., a drugs-of-abuse testing laboratory bas…

Read More



Victorville Community Hospital, Quest Diagnostics, ASCP, MIME

ASCP ACQUIRES MIME’S CYTOLOGY TRAINING AND PROFICIENCY TESTING IT WAS A BIG BREAK for pathologists and cytotechnologists involved in Pap testing. In a deal announced at the end of February, the American Society for Clinical Pathology (ASCP) has acquired “the complete cyt…

Read More



Bi-Annual Look at Trends Reshaping Clinical Labs

CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …

Read More



ARUP Laboratories, Ascension Health, IMPATH

ARUP SNAGS MAJOR HOSPITAL SEND-OUT PACT WITH ASCENSION HEALTH FOLLOWING AN EXHAUSTIVE RFP PROCESS, Ascension Health has selected ARUP Laboratories, Inc. to be its sole source provider of reference laboratory testing. This national agreement covers all 67 h…

Read More



Quiet Changes To Ripple Drugs-of-Abuse Market

CEO SUMMARY: Drugs-of-abuse (DOA) testing is an intensely-competitive market poised for significant change. Historically, national lab companies have been the major players and used rock-bottom prices to control the nation’s biggest corporate DOA clients. But since this line of testing …

Read More



ARUP & Mayo Respond To New Market Cycle

CEO SUMMARY: Since the beginning of 2002, several important events changed the competitive status quo among the nation’s leading providers of hospital send-out testing. As part of its ongoing assessment of this market segment, THE DARK REPORT provides strategic management insights from …

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;